Publications

Ediriwickrema A, Zhou J, Deng Y and Saltzman WM: Multi-layered nanoparticles for combination gene and drug delivery to tumors. Biomaterials. 2014 Aug 8; Epub 2014 Aug 8. PMID: 25112935

Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, Zhang Y, Sullivan DJ Jr, Piepmeier JM and Saltzman WM: Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A. 2013 Jul 16;110 (29) :11751-6. Epub 2013 Jul 1. PMID: 23818631

Patel T, Zhou J, Piepmeier JM and Saltzman WM: Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev. 2012 May 15;64 (7) :701-5. Epub 2011 Dec 20. PMID: 22210134


Zhou J, Patel TR, Fu M, Bertram JP and Saltzman WM: Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. Biomaterials. 2012 Jan;33 (2) :583-91. Epub 2011 Oct 19. PMID: 22014944


Zhou J, Atsina KB, Himes BT, Strohbehn GW and Saltzman WM: Novel delivery strategies for glioblastoma. Cancer J. 2012 Jan-Feb;18 (1) :89-99. PMID: 22290262

Zhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, Jiang Z and Saltzman WM: Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater. 2011 Dec 4;11 (1) :82-90. Epub 2011 Dec 4. PMID: 22138789


Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR and Liu JO: Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2011 Dec;91 Suppl 1 :S61-5. Epub 2011 Nov 23. PMID: 22115541


Liu J, Jiang Z, Zhou J, Zhang S and Saltzman WM: Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery. J Biomed Mater Res A. 2011 Feb;96 (2) :456-65. Epub 2010 Dec 9. PMID: 21171165

Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR and Liu JO: Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets. Chem Biol. 2010 Jan 29;17 (1) :86-97. PMID: 20142044

Zhou J and Zhang Y: Preclinical development of cancer stem cell drugs. Expert Opin Drug Discov. 2009 Jul;4 (7) :741-52. Epub 2009 Jun 9. PMID: 23489167


Zhou J, Zhang H, Gu P, Margolick JB, Yin D and Zhang Y: Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model. Breast Cancer Res Treat. 2009 May;115 (2) :269-77. Epub 2008 May 28. PMID: 18506619

Zhou J, Zhang H, Gu P, Bai J, Margolick JB and Zhang Y: NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat. 2008 Oct;111 (3) :419-27. Epub 2007 Oct 27. PMID: 17965935


Tao SC, Li Y, Zhou J, Qian J, Schnaar RL, Zhang Y, Goldstein IJ, Zhu H and Schneck JP: Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers. Glycobiology. 2008 Oct;18 (10) :761-9. Epub 2008 Jul 14. PMID: 18625848


Zhou J and Zhang Y: Cancer stem cells: Models, mechanisms and implications for improved treatment. Cell Cycle. 2008 May 15;7 (10) :1360-70. Epub 2008 Mar 19. PMID: 18418062

Byrne ST, Gu P, Zhou J, Denkin SM, Chong C, Sullivan D, Liu JO and Zhang Y: Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2007 Dec;51 (12) :4495-7. Epub 2007 Sep 17. PMID: 17876006


Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd and Zhang Y: Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A. 2007 Oct 9;104 (41) :16158-63. Epub 2007 Oct 2. PMID: 17911267